Atrás
NovaBay Pharmaceuticals Inc (NBY) Ganando
Gráfico del Precio de Acciones NBY
NBY Ganando
NovaBay Pharmaceuticals Inc
$1.55
12.68%
$0.17
Hasta hoy:Mar 24, 13:54:14 GMT-4
Estadísticas clave
Cierre Anterior
$1.37
Precio de apertura
$1.31
Rango del día
$1.28 - $1.75
Rango de 52 semanas
$1.11 - $99.75
Volumen
1.0M
Volumen promedio
509.9K
Rendimiento de dividendos
--
EPS (TTM)
-6.62
Cap. de mercado
$40.6M
¿Qué es NBY?
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.